202055 - European Medicines Agency (EMA) post-authorisation safety study of influenza vaccine

14/09/2015
02/07/2024
EU PAS number:
EUPAS10632
Study
Finalised
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

gsk-202055-protocol-redact

English (273.54 KB - PDF) View document
Study results
Study results

gsk-202055-clinical-study-report-redact

English (4.93 MB - PDF) View document
Study report
Other information